Perinatal outcomes associated with maternal HIV infection: A systematic review and meta-analysis

The Lancet HIV

Volumn 3, Issue 1, 2016, Pages e33-e48

  Wedi, Chrystelle O O ^a,c   Kirtley, Shona ^a   Hopewell, Sally ^a   Corrigan, Ruth ^a   Kennedy, Stephen H ^a   Hemelaar, Joris ^a,b,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

ARTICLE; CASE CONTROL STUDY; CLINICAL TRIAL (TOPIC); CONTROLLED CLINICAL TRIAL (TOPIC); HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOW BIRTH WEIGHT; META ANALYSIS; MONOTHERAPY; NEWBORN DEATH; OUTCOME ASSESSMENT; PATHOGENESIS; PERINATAL CARE; PREMATURE LABOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SCIENTIFIC LITERATURE; SENSITIVITY ANALYSIS; SPONTANEOUS ABORTION; STILLBIRTH; SYSTEMATIC REVIEW; VERY LOW BIRTH WEIGHT; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; TRANSMISSION; VERTICAL TRANSMISSION; VIROLOGY;

FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME;

EID: 84952882985     PISSN: None     EISSN: 23523018     Source Type: Journal    
DOI: 10.1016/S2352-3018(15)00207-6     Document Type: Article

References (68)

1. Millennium Development Goals report 2015 UN, (accessed Nov 19, 2015). http://www.un.org/millenniumgoals/2015_MDG_Report/pdf/MDG%202015%20rev%20(July%201).pdf.
2. The gap report 2014 UN Joint Programme on HIV/AIDS (UNAIDS), (accessed June 4, 2015). http://www.unaids.org/sites/default/files/media_asset/UNAIDS_Gap_report_en.pdf.
3. Lozano R, Wang H, Foreman KJ, et al. Progress towards Millennium Development Goals 4 and 5 on maternal and child mortality: an updated systematic analysis. Lancet 2011, 378:1139-1165.
4. Cousens S, Blencowe H, Stanton C, et al. National, regional, and worldwide estimates of stillbirth rates in 2009 with trends since 1995: a systematic analysis. Lancet 2011, 377:1319-1330.
5. Liu L, Oza S, Hogan D, et al. Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet 2015, 385:430-440.
6. Blencowe H, Cousens S, Oestergaard MZ, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 2012, 379:2162-2172.
7. Lee AC, Katz J, Blencowe H, et al. National and regional estimates of term and preterm babies born small for gestational age in 138 low-income and middle-income countries in 2010. Lancet Glob Health 2013, 1:e26-e36.
8. Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2197-2223.
9. Lawn JE, Blencowe H, Pattinson R, et al. Stillbirths: Where? When? Why? How to make the data count?. Lancet 2011, 377:1448-1463.
10. Lawn JE, Blencowe H, Oza S, et al. Every newborn: progress, priorities, and potential beyond survival. Lancet 2014, 384:189-205.
11. Cochrane handbook for systematic reviews of interventions 2008, Wiley-Blackwell Publishing, Chichester. J.P.T. Higgins, S. Green (Eds.).
12. Brocklehurst PFR The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis. BJOG 1998, 105:836-848.
13. Temmerman M, Chomba EN, Ndinya-Achola J, Plummer FA, Coppens M, Piot P Maternal human immunodeficiency virus-1 infection and pregnancy outcome. Obstet Gynecol 1994, 83:495-501.
14. Ndirangu J, Newell ML, Bland RM, Thorne C Maternal HIV infection associated with small-for-gestational age infants but not preterm births: evidence from rural South Africa. Hum Reprod 2012, 27:1846-1856.
15. Rollins NC, Coovadia HM, Bland RM, et al. Pregnancy outcomes in HIV-infected and uninfected women in rural and urban South Africa. J Acquir Immune Defic Syndr 2007, 44:321-328.
16. Adjorlolo G, Gayle H, Ekpini E, Sibailly T, Brattegaard K, De Cock KM. Prospective study of HIV-1 and HIV-2 mother-to-child transmission in Abidjan, Côte D'Ivoire. Proceeding of the 5th International Conference on AIDS; Quebec, Canada; June 17-18, 1991. M C 3053.
17. Ayisi JG, van Eijk AM, ter Kuile FO, et al. The effect of dual infection with HIV and malaria on pregnancy outcome in western Kenya. AIDS 2003, 17:585-594.
18. Bergstrom S, Sonnerborg A, Osman NB, Libombo A HIV infection and maternal outcome of pregnancy in Mozambican women: a case-control study. Genitourin Med 1995, 71:323-324.
19. Braddick MR, Kreiss JK, Embree JB, et al. Impact of maternal HIV infection on obstetrical and early neonatal outcome. AIDS 1990, 4:1001-1005.
20. Bulterys M, Chao A, Munyemana S, et al. Maternal human immunodeficiency virus 1 infection and intrauterine growth: a prospective cohort study in Butare, Rwanda. Pediatr Infect Dis J 1994, 13:94-100.
21. Coley JL, Msamanga GI, Fawzi MC, et al. The association between maternal HIV-1 infection and pregnancy outcomes in Dar es Salaam, Tanzania. BJOG 2001, 108:1125-1133.
22. Ezeaka VC, Iroha EO, Akinsulie AO, Temiye EO, Adetifa IM Anthropometric indices of infants born to HIV-1-infected mothers: a prospective cohort study in Lagos, Nigeria. Int J STD AIDS 2009, 20:545-548.
23. Friis H, Gomo E, Nyazema N, et al. Maternal body composition, HIV infection and other predictors of gestation length and birth size in Zimbabwe. Br J Nutr 2004, 92:833-840.
24. Habib NA, Daltveit AK, Bergsjø P, Shao J, Oneko O, Lie RT Maternal HIV status and pregnancy outcomes in northeastern Tanzania: a registry-based study. BJOG 2008, 115:616-624.
25. Ladner J, Leroy V, Hoffman P, et al. Chorioamnionitis and pregnancy outcome in HIV-infected African women. Pregnancy and HIV Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 1998, 18:293-298.
26. Lallemant M, Lallemant-Le-Coeur S, Cheynier D, et al. Mother-child transmission of HIV-1 and infant survival in Brazzaville, Congo. AIDS 1989, 3:643-646.
27. Lepage P, Dabis F, Hitimana DG, et al. Perinatal transmission of HIV-1: lack of impact of maternal HIV infection on characteristics of livebirths and on neonatal mortality in Kigali, Rwanda. AIDS 1991, 5:295-300.
28. Leroy V, Ladner J, Nyiraziraje M, et al. Effect of HIV-1 infection on pregnancy outcome in women in Kigali, Rwanda, 1992-1994. AIDS 1998, 12:643-650.
29. Mmiro FA, Ndungwa CM, Guy L, Galdforb J, Horm D, Olness K The effect of human immunodeficiency virus infection on the outcome of pregnancy in Ugandan women. J Obstet Gynaecol East Cent Afr 1993, 11:32-37.
30. Musana JW, Ojwang SB, Khisa W, Kiarie JN Pregnancy outcomes in mothers with advanced human immunodeficiency virus disease. East Afr Med J 2009, 86:480-485.
31. Mwanyumba F, Claeys P, Gaillard P, et al. Correlation between maternal and infant HIV infection and low birth weight: a study in Mombasa, Kenya. J Obstet Gynaecol 2001, 21:27-31.
32. Noble A, Ning Y, Woelk GB, Mahomed K, Williams MA Preterm delivery risk in relation to maternal HIV infection, history of malaria and other infections among urban Zimbabwean women. Cent Afr J Med 2005, 51:53-58.
33. Ryder RW, Nsa W, Hassig SE, et al. Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire. N Engl J Med 1989, 320:1637-1642.
34. Sutton MY, Sternberg M, Nsuami M, Behets F, Nelson AM, St Louis ME Trichomoniasis in pregnant human immunodeficiency virus-infected and human immunodeficiency virus-uninfected Congolese women: prevalence, risk factors, and association with low birth weight. Am J Obstet Gynecol 1999, 181:656-662.
35. Taha TE, Dallabetta GA, Canner JK, et al. The effect of human immunodeficiency virus infection on birthweight, and infant and child mortality in urban Malawi. Int J Epidemiol 1995, 24:1022-1029.
36. Ticconi C, Mapfumo M, Dorrucci M, et al. Effect of maternal HIV and malaria infection on pregnancy and perinatal outcome in Zimbabwe. J Acquir Immune Defic Syndr 2003, 34:289-294.
37. van den Broek NR, Jean-Baptiste R, Neilson JP Factors associated with preterm, early preterm and late preterm birth in Malawi. PLoS One 2014, 9:e90128.
38. Bucceri A, Luchini L, Rancilio L, et al. Pregnancy outcome among HIV positive and negative intravenous drug users. Eur J Obstet Gynecol Reprod Biol 1997, 72:169-174.
39. Johnstone FD, Raab GM, Hamilton BA The effect of human immunodeficiency virus infection and drug use on birth characteristics. Obstet Gynecol 1996, 88:321-326.
40. Alger LS, Farley JJ, Robinson BA, Hines SE, Berchin JM, Johnson JP Interactions of human immunodeficiency virus infection and pregnancy. Obstet Gynecol 1993, 82:787-796.
41. Ellis J, Williams H, Graves W, Lindsay MK Human immunodeficiency virus infection is a risk factor for adverse perinatal outcome. Am J Obstet Gynecol 2002, 186:903-906.
42. Halsey NA, Boulos R, Holt E, et al. Transmission of HIV-1 infections from mothers to infants in Haiti: impact on childhood mortality and malnutrition. JAMA 1990, 264:2088-2092.
43. Markson LE, Turner BJ, Houchens R, Silverman NS, Cosler L, Takyi BK Association of maternal HIV infection with low birth weight. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 13:227-234.
44. Maynard EC, Oh W, Indacochea F, Peter G Human immunodeficiency virus infection and pregnancy outcome in intravenous drug users. Am J Dis Child 1990, 144:1181-1213.
45. Selwyn PA, Schoenbaum EE, Davenny K, et al. Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users. JAMA 1989, 261:1289-1294.
46. Villar J, Cheikh Ismail L, Victora CG, et al. International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project. Lancet 2014, 384:857-868.
47. Ong CY, Liao AW, Spencer K, Munim S, Nicolaides KH First trimester maternal serum free β human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. BJOG 2000, 107:1265-1270.
48. Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH Vitamins in pre-eclampsia (VIP) trial Consortium. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet 2006, 367:1145-1154.
49. Lawn JE, Cousens S, Zupan J 4 million neonatal deaths: When? Where? Why?. Lancet 2005, 365:891-900.
50. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis (accessed Feb 20, 2015). http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
51. Harbord RM, Harris RJ, Sterne JAC Updated tests for small-study effects in meta-analyses. Stata J 2009, 9:197-210.
52. Moher D, Liberati A, TetzlaffJ, Altman DG Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009, 151:264-269.
53. Kumar RM, Uduman SA, Khurranna AK Impact of maternal HIV-1 infection on perinatal outcome. Int J Gynaecol Obstet 1995, 49:137-143.
54. Mitgitti R, Seanchaisuriya P, Schelp FP, Marui E, Yanai H Low birth weight infants born to HIV-seropositive mothers and HIV-seronegative mothers in Chiang Rai, Thailand. Southeast Asian J Trop Med Public Health 2008, 39:273-278.
55. Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR Recomm Rep 1994, 43:1-20. Centers for Disease Control and Prevention.
56. Papageorghiou AT, Kennedy SH, Salomon LJ, et al. International standards for early fetal size and pregnancy dating based on ultrasound measurement of crown-rump length in the first trimester of pregnancy. Ultrasound Obstet Gynecol 2014, 44:641-648.
57. Althabe F, Belizán JM, McClure EM, et al. A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial. Lancet 2015, 385:629-639.
58. Barros FC, Papageorghiou AT, Victora CG, et al. The distribution of clinical phenotypes of preterm birth syndrome: implications for prevention. JAMA Pediatr 2015, 169:220-229.
59. Kolte L, Gaardbo JC, Karlsson I, et al. Dysregulation of CD4+CD25+CD127lowFOXP3+ regulatory T cells in HIV-infected pregnant women. Blood 2011, 117:1861-1868.
60. Mikyas Y, Aziz N, Harawa N, et al. Immunologic activation during pregnancy: serial measurement of lymphocyte phenotype and serum activation molecules in HIV-infected and uninfected women. J Reprod Immunol 1997, 33:157-170.
61. Ackerman W, Kwiek JJ Role of the placenta in adverse perinatal outcomes among HIV-1 seropositive women. J Nippon Med Sch 2013, 80:90-94.
62. Kim HY, Kasonde P, Mwiya M, et al. Pregnancy loss and role of infant HIV status on perinatal mortality among HIV-infected women. BMC Pediatr 2012, 12:1-13.
63. Kourtis AP, Lee FK, Abrams EJ, Jamieson DJ, Bulterys M Mother-to-child transmission of HIV-1: timing and implications for prevention. Lancet Infect Dis 2006, 6:726-732.
64. Kourtis AP, Schmid CH, Jamieson DJ, Lau J Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis. AIDS 2007, 21:607-615.
65. Chen JY, Ribaudo HJ, Souda S, et al. Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana. J Infect Dis 2012, 206:1695-1705.
66. The global health sector strategy on HIV WHO, (accessed June 23, 2015). http://www.who.int/hiv/pub/progressreports/update2014/en/.
67. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV WHO, (accessed Nov 19, 2015). http://www.who.int/hiv/pub/guidelines/earlyrelease-arv/en/.
68. Townsend CL, Cortina-Borja M, Peckham CS, Tookey PA Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and Ireland. AIDS 2007, 21:1019-1026.